Thyroxine transfer from cerebrospinal fluid into choroid plexus and brain is affected by brefeldin A, low sodium, BCH, and phloretin, in ventriculo-cisternal perfused rabbits.
BACKGROUND
Thyroxine (T4) hormone is synthesized by the thyroid gland and then released into the systemic circulation where it binds to a number of proteins. Dysfunction in T4 transport mechanisms has been demonstrated in multiple central nervous system (CNS) diseases including Alzheimer's disease. In the presence of different compounds that inhibit potential T4 transport mechanisms, this study investigated the transfer of T4 from cerebrospinal fluid (CSF) into Choroid Plexus (CP) and other brain tissues. The compounds used were brefeldin A, low sodium artificial CSF (aCSF), BCH, phloretin, and taurocholate (TA).


METHODS
Radiolabeled T4 ((125)I-T4) was perfused continuously into the CSF and was assessed in several brain compartments with reference molecule (14)C-mannitol and blue dextran, using the in vivo ventriculo-cisternal perfusion (V-C) technique in the rabbit. The aCSF containing the drug of interest was infused after 1 h of perfusion. Drugs were applied independently to the aCSF after 1 h of control perfusion.


RESULTS
Of interest, in presence of low sodium or BCH, the percentage recovery of (125)I-T4, was increased compared to controls, with concomitant increase in T4 clearance. Conversely, brefeldin A, phloretin, and TA did not exert any significant effect on the recovery and clearance of (125)I-T4 assessed in aCSF. On the other hand, the uptake of (125)I-T4 into CP was raised by 18 fold compared to controls in the presence of brefeldin A. In addition, low sodium, BCH, or phloretin alone, enhanced the uptake of (125)I-T4 by almost 3-fold, whereas TA did not show any significant effect. Finally, the uptake and distribution of (125)I-T4 into other brain regions including ependymal region (ER) and caudate putamen (CAP) were significantly higher than in controls.


CONCLUSIONS
Our study suggests the involvement of different mechanisms for the transfer of (125)I-T4 from CSF into CP and other brain regions. This transfer may implicate sodium-dependent mechanisms, amino acid "L" system, or organic anion transporting polypeptide (OATP).
ER045, PRASE, Faculty of Sciences-I, Lebanese University Beirut, Lebanon ; Department of Biology, Faculty of Sciences-I, Lebanese University Beirut, Lebanon.
Kazem
K
Zibara
ER045, PRASE, Faculty of Sciences-I, Lebanese University Beirut, Lebanon ; Physics Department, Faculty of Sciences, Lebanese University Beirut, Lebanon.
Ali
A
El-Zein
Department of Biology, Faculty of Sciences-I, Lebanese University Beirut, Lebanon.
Wissam
W
Joumaa
Department of Family Medicine, University of Toledo Toledo, OH, USA.
Mohammad
M
El-Sayyad
Department of Neurosciences, University of Messina Messina, Italy.
Stefania
S
Mondello
ER045, PRASE, Faculty of Sciences-I, Lebanese University Beirut, Lebanon ; Department of Pharmacology and Therapeutics, Institute of Pharmaceutical Science, King's College London London, UK.
Nouhad
N
Kassem
blood-CSF barrier; blood-brain barrier; thyroid hormone; transport